US Stock MarketDetailed Quotes

LNTH Lantheus

Watchlist
  • 79.940
  • -2.020-2.46%
Close Feb 14 16:00 ET
  • 79.940
  • 0.0000.00%
Post 20:01 ET
5.56BMarket Cap13.28P/E (TTM)

About Lantheus Company

Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The firm develops products that help healthcare professionals in patient management and outcomes and assists clinicians with the detection of cardiovascular disease. It operates through the U.S. and International geographical segments. The U.S. segment produces and markets products, radiopharmacies, PMFs, integrated delivery networks, hospitals, clinics, and group practices throughout the United States. The International segment offers direct distribution in Canada and third-party distribution relationships in Europe, Canada, Australia, Asia-Pacific, Central America, and South America. The company was founded in 1956 and is headquartered in Bedford, MA.

Company Profile

SymbolLNTH
Company NameLantheus
Listing DateJun 25, 2015
Issue Price6.00
Founded1956
CEOMr. Brian A. Markison
MarketNASDAQ
Employees834
Fiscal Year Ends12-31
Address201 Burlington Road,South Building
CityBedford
ProvinceMassachusetts
CountryUnited States of America
Zip Code01730
Phone1-978-671-8001

Company Executives

  • Name
  • Position
  • Salary
  • Brian A. Markison
  • Chief Executive Officer
  • 539.11K
  • Dr. Jean-Claude Provost
  • Chief Science Officer
  • 3.08M
  • Etienne Montagut
  • Chief Business Officer
  • --
  • Daniel M. Niedzwiecki
  • Chief Administrative Officer, General Counsel and Corporate Secretary
  • 3.12M
  • Dr. Jeffrey S. Humphrey, M.D.
  • Chief Medical Officer
  • --
  • Amanda Morgan
  • Chief Commercial Officer
  • --
  • Robert J. Marshall, Jr
  • Chief Financial Officer and Treasurer
  • 4.33M
  • Kimberly Brown
  • Chief Accounting Officer
  • --
  • Mary Anne Heino
  • Chairman of the Board
  • 12.58M
  • Paul M. Blanchfield
  • President of the Company and Its Subsidiaries
  • 5.31M
  • Heinz Mausli
  • Independent Director
  • 480.00K
  • Dr. Gerard Ber, PhD
  • Independent Director
  • 470.81K
  • Dr. Phuong Khanh Morrow, F.A.C.P.
  • Independent Director
  • --
  • Samuel R. Leno
  • Independent Director
  • 493.31K
  • Gary John Pruden
  • Independent Director
  • 493.31K
  • Minnie V. Baylor-Henry
  • Independent Director
  • 477.89K
  • Julie H. McHugh
  • Lead Independent Director
  • 479.11K
  • Julie M. Eastland
  • Independent Director
  • --
  • Dr. James H. Thrall
  • Independent Director
  • 483.39K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.